Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibrx Biosciences

23.08
+0.01000.04%
Post-market: 23.080.00000.00%19:50 EDT
Volume:193.23K
Turnover:4.35M
Market Cap:334.10M
PE:0.21
High:23.80
Open:22.78
Low:20.84
Close:23.07
Loading ...
May 09, 2022

Major Issues Report

8-K - Current report
Apr 25, 2022

Major Issues Report

8-K - Current report
Apr 05, 2022

Major Issues Report

8-K - Current report
Apr 04, 2022

Major Issues Report

8-K - Current report
Mar 03, 2022

Major Issues Report

8-K - Current report
Mar 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 22, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Major Issues Report

8-K - Current report
Dec 01, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2021

Major Issues Report

8-K - Current report